glp 1 for crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1 for Crohn's Disease: Current
Description
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
Blocks the kidney protein that pulls glucose back into your blood, helping excrete sugar

Nearly half of GLP-1 patients now start therapy within a month of diabetes diagnosis

PlexusDx explains the interaction risks and how to manage both medications safely during your weight loss journey
